239 related articles for article (PubMed ID: 25579756)
21. [The gastric MALT lymphoma. An unforeseen model for studying the pathogenesis of the lymphomas].
Savio A
Recenti Prog Med; 2009 Jun; 100(6):311-21. PubMed ID: 19708303
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight.
Santacroce L; Cagiano R; Del Prete R; Bottalico L; Sabatini R; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Losacco T
Clin Ter; 2008; 159(6):457-62. PubMed ID: 19169609
[TBL] [Abstract][Full Text] [Related]
23. [Gastric MALT lymphoma and Helicobacter pylori].
Accardo D; Apuzzo M; Bazuro ME; Ferrara M; Tammaro G; Pippa G
Recenti Prog Med; 2000 Apr; 91(4):181-5. PubMed ID: 10804751
[TBL] [Abstract][Full Text] [Related]
24. Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.
Komoto M; Tominaga K; Nakata B; Takashima T; Inoue T; Hirakawa K
J Exp Clin Cancer Res; 2006 Jun; 25(2):283-5. PubMed ID: 16918142
[TBL] [Abstract][Full Text] [Related]
25. Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection.
Akamatsu T; Mochizuki T; Okiyama Y; Matsumoto A; Miyabayashi H; Ota H
Helicobacter; 2006 Apr; 11(2):86-95. PubMed ID: 16579838
[TBL] [Abstract][Full Text] [Related]
26. When can complete regression of low-grade gastric lymphoma of mucosa-associated lymphoid tissue be predicted after helicobacter pylori eradication?
Yamashita H; Watanabe H; Ajioka Y; Nishikura K; Maruta K; Fujino MA
Histopathology; 2000 Aug; 37(2):131-40. PubMed ID: 10931236
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
[TBL] [Abstract][Full Text] [Related]
28. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
[TBL] [Abstract][Full Text] [Related]
29. Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications.
Ferreri AJ; Ponzoni M; Viale E; Guidoboni M; Conciliis CD; Resti AG; Politi L; Lettini AA; Sacchetti F; Dognini G; Dolcetti R; Doglioni C
Hematol Oncol; 2006 Mar; 24(1):33-7. PubMed ID: 16385613
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
[TBL] [Abstract][Full Text] [Related]
31. Early-stage gastric MALT lymphomas: eradication of H. pylori and outcome.
Diz-Lois Palomares MT; Souto Ruzo J; Yáñez López JA; Alvarez García A; Arnal Monreal F; Vázquez-Iglesias JL
Rev Esp Enferm Dig; 2002 Nov; 94(11):669-78. PubMed ID: 12690990
[TBL] [Abstract][Full Text] [Related]
32. Eradication therapy is effective for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma.
Asano N; Iijima K; Terai S; Jin X; Ara N; Chiba T; Fushiya J; Koike T; Imatani A; Shimosegawa T
Tohoku J Exp Med; 2012 Nov; 228(3):223-7. PubMed ID: 23076291
[TBL] [Abstract][Full Text] [Related]
33. Regression of a primary gastric MALT lymphoma with extensive antrum lesions by Helicobacter pylori eradication.
Cammarota G; Tursi A; Cannizzaro O; Papa A; Cuoco L; Cianci R; Fedeli P; Fedeli G; Gasbarrini G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):361-4. PubMed ID: 9476192
[TBL] [Abstract][Full Text] [Related]
34. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial.
Steinbach G; Ford R; Glober G; Sample D; Hagemeister FB; Lynch PM; McLaughlin PW; Rodriguez MA; Romaguera JE; Sarris AH; Younes A; Luthra R; Manning JT; Johnson CM; Lahoti S; Shen Y; Lee JE; Winn RJ; Genta RM; Graham DY; Cabanillas FF
Ann Intern Med; 1999 Jul; 131(2):88-95. PubMed ID: 10419446
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients.
Bilgilier C; Simonitsch-Klupp I; Kiesewetter B; Raderer M; Dolak W; Makristathis A; Steininger C
Ann Hematol; 2016 Jun; 95(7):1115-20. PubMed ID: 27091350
[TBL] [Abstract][Full Text] [Related]
36. Early cancer of the stomach arising after successful treatment of gastric MALT lymphoma in patients with autoimmune disease.
Raderer M; Püspök A; Stummvoll G; Längle F; Chott A
Scand J Gastroenterol; 2003 Mar; 38(3):294-7. PubMed ID: 12737445
[TBL] [Abstract][Full Text] [Related]
37. Gastric MALT lymphomas: the value of an endoscopic follow-up evaluation.
Agresta F; Trentin G; Mainente P; Della Libera D; Bianco A; Salvagno L
Surg Endosc; 2000 Dec; 14(12):1153-5. PubMed ID: 11148787
[TBL] [Abstract][Full Text] [Related]
38. Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy.
Gobbi PG; Corbella F; Valentino F; Bergonzi M; Sangalli C; Perfetti V; Corazza GR
Ann Oncol; 2009 Mar; 20(3):465-8. PubMed ID: 19074214
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease.
Kim JS; Chung SJ; Choi YS; Cheon JH; Kim CW; Kim SG; Jung HC; Song IS
Br J Cancer; 2007 May; 96(9):1324-8. PubMed ID: 17406363
[TBL] [Abstract][Full Text] [Related]
40. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.
Sumida T; Kitadai Y; Hiyama T; Shinagawa K; Tanaka M; Kodama M; Masuda H; Ito M; Tanaka S; Yoshihara M; Chayama K
Cancer Sci; 2009 Jun; 100(6):1075-81. PubMed ID: 19385974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
